Catalyst Wire Dossier Catalyst Wire Dossier

REGN5069

· Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN5069, covering 2021-07-01 to 2021-07-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Examine the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee [Phase 2]

See pricing